Purchase Order 36C24226P0526
Award Date 3/26/26
Potential Completion Date 6/26/26
Potential Value $16K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Memphis, TN 38141, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 2, awarded a firm fixed-price purchase order to CoverMyMeds Pharmacy LLC for the emergency procurement of Pomalyst 3 mg capsules (NDC 59572-0503-21) with a ceiling value of $16,331.35. The contract was awarded on February 26, 2026, with an ultimate completion date of March 5, 2026, reflecting the urgent nature of this pharmaceutical acquisition. The place of performance is located in Memphis, Tennessee. No set-aside...
- Bristol-Myers Squibb Company, a global biopharmaceutical manufacturer, received a delivery order valued at $16,421.95 for Pomalidomide (Pomalyst) 4mg capsules from Veterans Integrated Service Network 5 (VISN 5), a civilian component of the Department of Veterans Affairs. This firm fixed-price contract, awarded on February 3, 2026, with an ultimate completion date of February 6, 2026, carries no set-aside designation. The order will be fulfilled from the company's Lawrenceville, New Jersey...
- Bristol-Myers Squibb Company received a delivery order valued at $16,421.95 under its Federal Supply Schedule contract with the Department of Veterans Affairs to supply Pomalyst (pomalidomide) 2mg and 4mg tablets for patient medication to Veterans Integrated Service Network 5, with a completion date of February 25, 2026. This order is issued under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule contract (ID: 36F79724D0101), which carries a substantial ceiling value of $12.28 billion...
- Bristol-Myers Squibb Company has been awarded a delivery order valued at $127,169.40 for the supply of POMALYST (pomalidomide) in 2 mg and 4 mg formulations to support the Department of Veterans Affairs' Veterans Integrated Service Network 5 (VISN 5). This firm fixed-price contract is issued as a call against Bristol-Myers Squibb's existing Federal Supply Schedule contract (FSS-61-IB: Pharmaceuticals and Drugs) with the VA, which carries a ceiling value of $12.3 billion and extends through April...
- Covermymeds Pharmacy LLC was awarded a firm fixed-price purchase order valued at $872,325.86 by the Veterans Integrated Service Network 8 (VISN 8), a civilian agency within the Department of Veterans Affairs. The contract, awarded on January 16, 2026, with an ultimate completion date of April 17, 2026, covers pharmacy services to be performed in Memphis, Tennessee. No set-aside designation was applied to this award. VISN 8 serves veterans across a multi-state region and coordinates healthcare...
- Bristol-Myers Squibb Company, a global biopharmaceutical manufacturer headquartered in Lawrenceville, New Jersey, has been awarded a delivery order for POMALYST 3 MG by Veterans Integrated Service Network 5 (VISN 5), a civilian component of the Department of Veterans Affairs. This Blanket Purchase Agreement (BPA) call, issued on March 20, 2026, carries a ceiling value of $10,887.52 and is structured as a firm fixed-price contract with an ultimate completion date of March 27, 2026. The award...
- The Defense Logistics Agency awarded a delivery order valued at $27,703.52 to AmerisourceBergen Drug Corp on September 28, 2025, for the supply of Pomalyst (pomalidomide) 4 mg capsules in a 21-count package. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of October 20, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- Bristol-Myers Squibb Company has been awarded a delivery order valued at $356,543.20 under its Federal Supply Schedule contract with the Department of Veterans Affairs, Veterans Integrated Service Network 5. The order, issued on January 29, 2026 with completion targeted for September 30, 2026, covers the supply of Mavacamten (Camzyos) and Pomalidomide (Pomalyst) to support VA healthcare operations in Memphis, Tennessee. This delivery order is issued under Bristol-Myers Squibb's existing...
- Bristol-Myers Squibb Company received a delivery order award from Veterans Integrated Service Network 5 (VISN 5) for Pomalyst 3mg capsules, a specialty oncology pharmaceutical used in cancer treatment. The contract, awarded on February 26, 2026, carries a ceiling value of $10,887.52 with a firm fixed-price structure and an ultimate completion date of March 6, 2026. This delivery order was issued under Bristol-Myers Squibb's Federal Supply Schedule contract (ID: 36F79724D0101) for Pharmaceuticals...
- Bristol-Myers Squibb Company has been awarded a delivery order valued at $911,453.97 by the Department of Veterans Affairs' Veterans Integrated Service Network 12 for the supply of specialty pharmaceuticals including REVLIMID, POMALYST, and CAMZYOS. This firm fixed-price delivery order, awarded on January 13, 2026, with an ultimate completion date of January 12, 2027, will be performed at the company's Lawrenceville, New Jersey facility. The award carries no set-aside designation, reflecting...